👉 The British Pharmacological Society (BPS) has been at the forefront of research into blood pressure (BP) management, particularly focusing on the development and evaluation of new antihypertensive drugs. Their research encompasses a wide range of methodologies, from preclinical studies using animal models to clinical trials in human subjects, aiming to identify novel therapeutic targets and optimize existing treatments. A key area of focus is understanding the mechanisms by which different classes of antihypertensives—such as ACE inhibitors, ARBs, calcium channel blockers, and diuretics—affect BP regulation. The BPS also collaborates with international partners to advance personalized medicine approaches, exploring how genetic and lifestyle factors influence individual responses to these medications. Their findings contribute significantly to clinical guidelines and the development of more effective, safer, and tailored treatments for hypertension.